Saskatoon, Saskatchewan--(Newsfile Corp. - June 26, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the results of its 2025 annual meeting of shareholders (the " Meeting ") held on June 26, 2025. At the Meeting, all director nominees listed in the Company's management information circular dated May 28, 2025 were elected by shareholders as directors... Read More

Distribution agreement in Canada under MustGrow's sales and distribution division NexusBioAg. RhizoSorb ® releases nutrients in the soil more efficiently to reduce phosphorus use by up to 50% while maximizing crop yield. Sustainable production and responsible use of phosphorus is critical to support global food demands. Saskatoon, Saskatchewan--(Newsfile Corp. - June 10, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB:... Read More

Investor Webcast: Wednesday, May 28th at 4:00pm ET / 1:00pm PT Register/View Here: https://us02web.zoom.us/webinar/register/6217478678603/WN_h8uMVWINQsmS3HWF8K59Wg Please join/register at least 5 minutes prior to the call. Questions emailed to info@mustgrow.ca will be addressed during the Q&A portion of the webcast. Saskatoon, Saskatchewan--(Newsfile Corp. - May 27, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB:... Read More

Saskatoon, Saskatchewan--(Newsfile Corp. - April 1, 2025) - MustGrow Biologics Corp . (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company " or " MustGrow "), a leading provider of biological and regenerative agriculture solutions, is pleased to announce the addition of three cutting-edge biological solutions to MustGrow's existing Canadian product lines through its recently acquired Canadian sales and distribution... Read More

Saskatoon, Saskatchewan--(Newsfile Corp. - February 11, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company " or " MustGrow "), a leading provider of biological and regenerative agriculture solutions, is pleased to announce a five-year exclusive distribution agreement was signed on February 4, 2025 (the " Agreement ") with Adjuvants Plus Inc. (" Adjuvants "), a Canadian regenerative... Read More

Saskatoon, Saskatchewan--(Newsfile Corp. - January 16, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company " or " MustGrow ") is pleased to announce the closing of the previously announced non-brokered private placement of units (each, a " Unit ") at a price per Unit of $1,000 for aggregate gross proceeds to the Company of $2,585,000 (the " Private Placement ") on January 16, 2025 (the "... Read More

Saskatoon, Saskatchewan--(Newsfile Corp. - January 2, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce the execution and closing of an Asset Purchase Agreement (the "APA") dated December 31, 2024 with Univar Solutions Canada Ltd. ("Univar Solutions") for the acquisition of certain assets that represent NexusBioAg ("NexusBioAg"). MustGrow's... Read More

Saskatoon, Saskatchewan--(Newsfile Corp. - December 11, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company " or " MustGrow ") is pleased to announce a proposed non-brokered private placement of approximately 2,000 units (each, a " Unit ") at a price per Unit of $1,000 for aggregate gross proceeds of approximately $2,000,000 (with an option to increase the size of the private placement by... Read More

Saskatoon, Saskatchewan--(Newsfile Corp. - November 27, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company " or " MustGrow ") is pleased to announce the signing of a non-binding term-sheet (the " Term Sheet ") dated November 27, 2024 with Univar Solutions Canada Ltd. (" Univar Solutions ") for the proposed acquisition of certain assets that represent NexusBioAg (" NexusBioAg "). This... Read More

MustGrow transitions from R&D to commercialization. TerraSante TM biofertility product manufacturing and sales has commenced, with potential initial sales ramp-up in 2025 and 2026. Commercialization of TerraMG TM soil biopesticide is progressing under the Bayer commercial agreement in the EU, Middle East and Africa. Registration work for TerraMG TM soil biopesticide continues in the U.S. and Canada. Expiration of exclusive... Read More

MustGrow will be receiving funding from Agriculture and Agri-Food Canada to investigate mustard-derived ingredient opportunities in human & animal health applications. Potential product opportunities may include application in functional foods and nutraceuticals for improved immunity and gut health in humans, as natural food preservatives, as well as a replacement for antibiotics in animal feeds. Saskatoon,... Read More

MustGrow has received approval from the Florida Department of Agriculture and Consumer Services to commence sales of TerraSante TM , an organic biofertility product, in the State of Florida. Mustard-derived TerraSante TM focuses on soil and soil microbiome health, nutrient/water use efficiencies, and plant yields. Saskatoon, Saskatchewan--(Newsfile Corp. - September 11, 2024) - MustGrow Biologics Corp . (TSXV: MGRO) (OTCQB:... Read More

Saskatoon, Saskatchewan--(Newsfile Corp. - September 4, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") today announced that the board of directors of the Company authorized and approved the grant of a total of 1,575,398 deferred share units (" DSUs ") and restricted share units (" RSUs ") to certain directors, officers, and consultants of the Company, effective September... Read More

MustGrow has received the Arizona Department of Agriculture approval to commence sales of TerraSante TM , an organic biofertility product, in the State of Arizona. Mustard-derived TerraSante TM focuses on soil and soil microbiome health, nutrient/water use efficiencies, and plant yields. Saskatoon, Saskatchewan--(Newsfile Corp. - August 22, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "... Read More

MustGrow has received the Idaho State Department of Agriculture approval to commence sales of TerraSante TM , an organic biofertility product, in Idaho. Mustard-derived TerraSante TM focuses on soil and soil microbiome health, nutrient/water use efficiencies, and plant yields. Saskatoon, Saskatchewan--(Newsfile Corp. - July 31, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company " or "... Read More

MustGrow to attend annual Strawberry Center Field Day at Cal Poly to promote biofertility product TerraSante TM to hundreds of strawberry growers, researchers, and farming industry representatives. MustGrow engages services of 17-year Nutrien sales veteran Michael Atkins to accelerate California sales efforts. Mustard-derived TerraSante TM focuses on soil microbiome health, nutrient/water use efficiencies, and plant yields.... Read More

MustGrow joins alliance of international banana leaders, including Bayer, Chiquita, Del Monte, Dole, and Fyffes. MustGrow is collaborating to bring its uniquely effective technologies to help address this global issue. MustGrow's mustard-derived biofungicide has shown efficacy versus TR4. Saskatoon, Saskatchewan--(Newsfile Corp. - July 9, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company... Read More

Saskatoon, Saskatchewan--(Newsfile Corp. - June 27, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the results of its 2024 annual meeting of shareholders (the " Meeting ") held on June 27, 2024. At the Meeting, shareholders approved all director nominees listed in the Company's management information circular dated May 28, 2024 were elected as... Read More

MustGrow has received the California Department of Food Agriculture approval to commence sales of TerraSante TM , an organic biofertility product, in California. Additionally, MustGrow has received organic certification from California's Organic Input Material (OIM) Program. Mustard-derived TerraSante TM focuses on soil microbiome health, nutrient/water use efficiencies, and plant yields. Saskatoon, Saskatchewan--(Newsfile... Read More

G.S. Long Co., Inc. has exclusive distribution rights for MustGrow's TerraSante TM biofertility product in Oregon and Washington State. MustGrow's mustard-derived TerraSante TM is organic certified through the USDA National Organic Program (OMRI Listed®). TerraSante TM focuses on soil microbiome health, nutrient/water use efficiencies, and plant yields. Saskatoon, Saskatchewan--(Newsfile Corp. - May 2, 2024) - MustGrow... Read More

MustGrow Biologics to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 Saskatoon, Saskatchewan--(Newsfile Corp. - April 17, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company " or " MustGrow ") is pleased to announce it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 9:30 AM... Read More

MustGrow has received The State of Oregon Agriculture approval to commence sales of TerraSante TM , an organic biofertility product, in Oregon State. MustGrow's recently-awarded organic compliance certification from the USDA National Organic Program (OMRI Listed®) will apply to this Registration. Mustard-derived TerraSante TM focuses on soil microbiome health, nutrient/water use efficiencies, and plant yields. Saskatoon,... Read More

Saskatoon, Saskatchewan--(Newsfile Corp. - December 13, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (" MustGrow ") wishes to provide additional information about the collaboration agreement (the " Agreement ") with Bayer AG (" Bayer ") which was announced December 11, 2023. The Agreement is a license and collaboration agreement enabling Bayer to further evaluate certain soil applications of... Read More

MustGrow Biologics CEO Corey Giasson joined Steve Darling from Proactive to share news the company has signed a collaboration agreement with Bayer AG that focuses on the soil applications of MustGrow's mustard-based biocontrol technologies across Europe, the Middle East, and Africa (EMEA). It's important to note that this collaboration excludes home and garden, turf, and ornamental applications. Under this collaboration... Read More

Bayer's commercial license covers soil applications of MustGrow's mustard-based biocontrol technologies in Europe, Middle East and Africa. MustGrow to receive upfront license fees and milestone payments, royalties, and manufacturing sales linked to development and commercial achievements. Saskatoon, Saskatchewan--(Newsfile Corp. - December 11, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) ("... Read More

MustGrow Biologics chief executive officer Corey Giasson joined Steve Darling from Proactive to share news regarding the approval of TerraSante crop fertilizer and soil amendment products by the Washington State Department of Agriculture. This development comes on the heels of MustGrow Biologics receiving organic compliance certification from the USDA National Organic Program. With the approval from the Washington State... Read More

Washington State Department of Agriculture Fertilizer Registration Certificate received to commence sales of TerraSante TM crop fertilizer and soil amendment product in Washington State. MustGrow's recently-awarded organic compliance certification from the USDA National Organic Program (OMRI Listed®) will apply to this Registration. Mustard-derived TerraSante TM focuses on soil microbiome health, nutrient/water use... Read More

The Company invites market participants to attend in online at VirtualInvestorConferences.com Saskatoon, Saskatchewan--(Newsfile Corp. - November 9, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company " or " MustGrow ") is pleased to announce Corey Giasson, MustGrow's President & CEO, will present live at the Global SMID Cap Investor Conference, hosted by Harbor Access Investor Relations... Read More

Approval from Health Canada's Pest Management Regulatory Agency (PMRA) to commence large-scale farmer trials. Program to focus on MustGrow's TerraMG™ mustard-derived soil biopesticide technology for use in Canadian canola and pulse crop markets. NexusBioAg's 2024 BioAdvantage Trials (BAT) Program to evaluate large-scale efficacy and commercial value potential. MustGrow and NexusBioAg are committed to launching innovative,... Read More

MustGrow Biologics chief operating officer Colin Bletsky joined Steve Darling from Proactive to share significant news the company’s Terrasante crop fertilizer and soil amendment technology has received USDA organic approval, marking a noteworthy achievement in the field of organic agricultural products. Terrasante has been granted organic certification from the Organic Materials Review Institute (OMRI) and is now OMRI... Read More

USDA National Organic Program (OMRI Listed ® ) has awarded MustGrow's TerraSante TM Crop Fertilizer and Soil Amendment technology with organic compliance. TerraSante TM is a mustard plant-based technolgy focused on soil and soil microbiome health, nutrient and water use efficiencies, and plant yields. MustGrow plans to continue to advance its TerraSante TM registration approval process in key U.S. states. Saskatoon,... Read More

Saskatoon, Saskatchewan--(Newsfile Corp. - October 19, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") will be participating in next week's Annual Biocontrol Industry Meeting ("ABIM") in Basel, Switzerland from October 23 rd to 25 th . ABIM is regarded as the premier event in the biocontrol industry. From policy makers, to farmers, to the end product users, global... Read More

Saskatoon, Saskatchewan--(Newsfile Corp. - September 12, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce the engagement of Harbor Access LLC ("Harbor Access") to perform investor relations services and activities, as defined in accordance with the policies of the TSX Venture Exchange ("TSXV") and applicable securities laws. "In connection with... Read More

Exclusive agreement with Janssen PMP to now include postharvest potatoes and bananas globally, a significant strengthening of existing partnership. Janssen PMP postharvest research, development, and commercialization capabilities have driven expansion. Janssen PMP will continue to fund and complete all application testing and development work. Saskatoon, Saskatchewan--(Newsfile Corp. - September 6, 2023) - MustGrow Biologics... Read More

Saskatoon, Saskatchewan--(Newsfile Corp. - September 1, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), today announced that the board of directors of the Company authorized and approved the grant of a total of 612,757 deferred share units ("DSUs") and 177,035 restricted share units ("RSUs") to certain directors, officers, and consultants of the Company, effective August... Read More

Annual Awards Program Recognizes Innovation in Agricultural and Food Technologies Around the Globe Saskatoon, Saskatchewan--(Newsfile Corp. - August 17, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) ("MustGrow"), an agricultural biotechnology company focused on providing science-based biological solutions for high-value crops, today announced it is the winner of the "AgTech Innovation of the Year"... Read More

Saskatoon, Saskatchewan--(Newsfile Corp. - June 29, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the results of its 2023 annual meeting of shareholders (the " Meeting ") held on June 29, 2023. At the Meeting, shareholders approved the setting of the number of directors of the Company at seven and all director nominees listed in the Company's... Read More

Succesful completion of initial commercial run-rate production via third-party contract manufacturer. Production run-rate of the extract reached greater than the equivalent of 5,000 litres per day of MustGrow's mustard plant-based biocontrol liquid technology. Estimated equivalent annual capacity equates to approximately US$25 million in grower level revenue without the need to construct capital intensive production... Read More

Mustard plant-based development programs to focus on soil and microbiome health, nutrient and water use efficiencies, and plant yields. Initial focus in Washington, Oregon, California, Arizona, then U.S. nationwide. Saskatoon, Saskatchewan--(Newsfile Corp. - June 5, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the signing of a Contract Services... Read More

Exclusive agreement with Janssen PMP, a division of Janssen Pharmaceutica NV, to test MustGrow's mustard-based postharvest food storage preservation technologies for certain applications globally has been extended. Janssen PMP will continue to fund and drive all testing and development work. Saskatoon, Saskatchewan--(Newsfile Corp. - May 23, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the... Read More

Saskatoon, Saskatchewan--(Newsfile Corp. - April 24, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), announces that it will be hosting an investor webcast on Wednesday, April 26th at 4:00pm ET. MustGrow's management team will be presenting on recent corporate progress, biological industry developments, and upcoming catalysts. The presentation will be followed by an... Read More

Plant-based programs to focus on soil and microbiome health, nutrient and water use efficiencies, and plant yields. Products to utilize multiple plant-derived extracts in addition to (and including) the mustard plant to improve beneficial microbial activity and soil health. Soil Amendment and Biofertility are expected to increase MustGrow's target market opportunity in addition to its existing Biocontrol focus. Existing... Read More

MustGrow Biologics CEO Corey Giasson joined Steve Darling from Proactive to share news the company has seen its portfolio of patents grow exponentially. Giasson tells Proactive its IP portfolio has grown from 23 to 84 total patents issued and pending over the last three years. In fact, 62 have been issued which is an increase from 18 issued patents three years ago. Contact Details Proactive Canada +1 604-688-8158... Read More

Mustard-derived intellectual property portfolio has significantly advanced in quantity and scope. Patents have been filed across six continents. Patent portfolio has grown from 23 to 84 in three year period. Saskatoon, Saskatchewan--(Newsfile Corp. - March 8, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to report on the growth of its intellectual property... Read More

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company " or " MustGrow "), is pleased to announce that the TSX Venture Exchange (" TSXV ") has approved the Company's application to list its common shares (the " Shares ") on the TSXV. The Shares will commence trading on the TSXV under the ticker symbol " MGRO " at the opening of the Market on November 11, 2022. Shareholders will not be required to take... Read More

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company " or " MustGrow "), is pleased to announce that it has received conditional approval to list its common shares on the TSX Venture Exchange (the "TSXV"). The listing is subject to the Company fulfilling certain requirements of the TSXV in accordance with the terms of its conditional approval letter dated October 6, 2022. MustGrow is actively working... Read More

Soil biofumigation platform continues to show promising results across multiple continents. Postharvest activities in potatoes, fruits and vegetables have demonstrated initial efficacy and work is now focused on application, timing, dose rates and residues. Bioherbicide optimization and formulation work advances. MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company " or " MustGrow "), and its global... Read More

Sumitomo Corporation has extended the option for exclusive testing with MustGrow's technology for preplant soil fumigation, bioherbicide, postharvest and food preservation for potatoes, and bananas in North, Central, and South America. Sumitomo Corporation continues to demonstrate positive levels of efficacy utilizing MustGrow's technology in comparison to synthetic chemical standards. Sumitomo Corporation to continue... Read More

Univar Solutions Inc. (NYSE: UNVR) (" Univar Solutions "), a leading global solutions provider to users of specialty ingredients and chemicals, announced today that NexusBioAg, a division of Univar Solutions, and MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (" MustGrow "), an agricultural biotechnology company focused on providing science-based biological solutions for high-value crops, have reached an... Read More

MustGrow Biologics Corp. ( CSE: MGRO , OTC: MGROF , FRA: 0C0 ) (" MustGrow " or the " Company ") announces that it has filed a final short form base shelf prospectus (the " Shelf Prospectus ") with securities regulatory authorities in each province of Canada. "The Shelf Prospectus will provide us with greater flexibility to access capital on an expedited basis if and when required during the 25 month period it is expected to... Read More

Exclusive agreement with Janssen PMP, a division of Janssen Pharmaceutica NV, to test MustGrow's mustard-based postharvest food storage preservation technologies for certain applications globally. Janssen PMP will fund and drive all testing and development work. MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company ", " MustGrow "), and JANSSEN PMP , a division of Janssen Pharmaceutica NV , one of the... Read More

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company ", " MustGrow ") is pleased to announce the appointment of Ms. Laura Westby, Senior Vice President - Legal and Intellectual Property at Invaio Sciences, to its Board of Directors. Ms. Westby will leverage her extensive business and legal experience in international agriculture, specifically around commercial arrangements, strategy and intellectual... Read More

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company ", " MustGrow "), is pleased to provide an update of its organic mustard plant-derived crop protection technology pipeline. MustGrow has harnessed the mustard seed's natural defense mechanism for treatment of diseases, pests, and weeds. REMINDER :... Read More

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company ", " MustGrow "), an agriculture biotechnology company focused on providing organic biological crop protection solutions, announces an investor webcast to discuss its two major global partnerships with leading agriculture companies. MustGrow's management team will be discussing and answering questions about the importance of these exclusive... Read More

Successful postharvest study in both Fusarium dry rot disease control and sprout suppression MustGrow's mustard-based technology outperformed leading synthetic chemical standards No combination treatment products currently exist that address both disease and sprouting Potato postharvest program may now transition to Sumitomo... Read More

Exclusive agreement with Bayer to evaluate MustGrow's technologies to determine commercial potential. Bayer has the option to acquire exclusive rights to MustGrow's technologies for preplant soil fumigation, bioherbicide applications and postharvest food preservation of potatoes including sprout inhibition in the regions of Europe, Asia Pacific, Middle East and Africa. Bayer will fund and drive all laboratory, field... Read More

Successful US field trials in cotton, soybeans and cucurbits MustGrow's mustard-based technology showed efficacy comparable to synthetic chemical standards for treatment of multiple nematode species Sumitomo Corporation to expand program development into Mexico, Peru and Chile Joint regulatory strategy being implemented across the Americas MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (" MustGrow "), working... Read More

Field data confirmed reduced incidence and severity of Fusarium wilt TR4 symptoms in banana plants after application of MustGrow's product. No damage or phytotoxic effects on banana plants, even at higher dose rates. Colombia banana program transitions to Sumitomo Corporation. Sumitomo Corporation to drive project and field development, as well as regulatory work necessary for commercialization. MustGrow Biologics Corp.... Read More

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (" MustGrow ") is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its key stakeholders - potential industry partners, shareholders and prospective investors - by increasing awareness of its natural mustard plant-based crop protection technologies. Adelaide Capital Ag Tech Conference - Institutional Investment... Read More

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (" MustGrow ") is pleased to announce the closing of its previously-announced non-brokered private placement (the " Private Placement "). MustGrow has closed on an aggregate of 2,726,611 units for gross proceeds of C$7,089,189 effective October 6, 2021. Included in this sum, Ira Gluskin and Gluskin-related parties have invested C$1.0 million under the same terms... Read More

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (" MustGrow ") is pleased to announce it has upsized its previously-announced C$2.0 million non-brokered private placement (the " Private Placement ") to approximately 2.7 million units (each a " Unit ") for gross proceeds of approximately C$6.9 million at a price per Unit of C$2.60. Ira Gluskin and Gluskin-related parties have subscribed to invest C$1.0 million... Read More

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) (" MustGrow ") is pleased to announce a non-brokered private placement (the " Private Placement ") of approximately 770,000 units (each a " Unit ") for gross proceeds of approximately C$2.0 million at a price per Unit of C$2.60. Each Unit shall consist of one common share of the Company and one-half of one common share purchase warrant (each a " Warrant "). Each... Read More

Exclusive agreement with Sumitomo Corporation to evaluate MustGrow's technology to determine commercial potential. Sumitomo Corporation has option to acquire exclusive rights to MustGrow's technology for preplant soil fumigation, bioherbicide, postharvest and food preservation for potatoes, and bananas in North, Central, and South America. Sumitomo Corporation to fund and drive all field development, including toxicology,... Read More

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (" MustGrow ") is pleased to announce positive results from its non-exclusive floriculture trials (the " Carnation Trials ") in Colombia with Gowan Group (" Gowan "), a global, private family-owned agriculture solutions business specializing in developing, marketing, and manufacturing global agriculture inputs such as crop protection products, seeds and... Read More

Disease control of root-rot Aphanomyces in greenhouse testing across a range of economic rates. Plants treated with MustGrow's biopesticide were robust in plant and root system health. Aphanomyces is a soil-borne root-rot disease that destroys pulse crops (peas, lentils, and legumes). 90% of Saskachewan pulse crop fields have... Read More

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the " Company ", " MustGrow "), an agriculture technology company focused on providing natural biological crop protection solutions, will discuss ( via live webcast ) recent achievements and upcoming catalysts. Live Webcast TODAY : Tuesday, May 4 th at 4:10pm ET ( Register/View Here ) Please email questions to info@mustgrow.ca to be addressed following the... Read More

Field Trials to commence for MustGrow's mustard-derived soil biopesticide in Canada for treatment of Clubroot disease in Canola and Aphanomyces disease in Pulse Crops. MustGrow's organic biopesticide is plant-based, harnessing the mustard seed's natural defense mechanism to control diseases, insect pests, and weeds. MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (" MustGrow ") and Univar Canada Ltd.'s... Read More

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the " Company ", " MustGrow ") is pleased to outline its environmentally-sustainable approach to crop protection on Earth Day . MustGrow's safe and effective natural, organic biofumigant, biopesticide and bioherbicide are plant-based - harnessing the mustard seed's natural defense mechanism to control diseases, insect pests and weeds. This natural biological... Read More

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the " Company ", " MustGrow ") is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its key stakeholders - potential industry partners, shareholders and prospective investors - by increasing awareness of its natural mustard plant-based biopesticide technologies. SnowCap Ventures - The Future of Food 2.0... Read More

Comparable efficacy and yield results with MustGrow's natural mustard-derived biological products versus Chloropicrin. Field study funded via collaboration with a 3 rd party research organization. MustGrow's organic biopesticide is plant-based, harnessing the mustard seed's natural defense mechanism to control diseases, insect pests and weeds. MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (" MustGrow ") is... Read More

MustGrow has isolated and concentrated a new mustard-derived extract, thiocyanate . Thiocyanate is soil active and translocated in the plant as a systemic, non-selective bioherbicide (natural weed-killer). Greenhouse weed treatment studies have commenced with this new bioherbicide extract. MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the " Company ", " MustGrow ") is pleased to announce that it has... Read More

Regulatory approval received in Canada. Bio-fungicide product for powdery mildew suppression treatment on cannabis and hemp. Product is licensed exclusively from leading multinational biological company. MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the " Company ", " MustGrow ") is pleased to announce receipt of regulatory approval for a powdery mildew bio-fungicide product for use on cannabis and hemp... Read More

100% control of Fusarium wilt TR4 disease at economic rates as low as 5 gal/acre (49 L/ha). National State of Emergency declared in Colombia in 2019. Fusarium wilt TR4 is existential threat to the $25 billion global banana industry. MustGrow advancing to field study trials. S MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company ", " MustGrow ") is pleased to announce further laboratory results of its... Read More

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the " Company ", " MustGrow ") is pleased to announce its upcoming awareness initiatives. MustGrow continues to actively engage its key stakeholders - potential industry partners, shareholders and prospective investors - by increasing awareness of its natural mustard plant-based crop protection products. CSE Tech Tuesdays - Virtual Public Company Showcase... Read More